Iron salt supplementation during gestation and gestational diabetes mellitus
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista de Saúde Pública |
Texto Completo: | https://www.revistas.usp.br/rsp/article/view/219139 |
Resumo: | OBJETIVE: To evaluate the association between the use of iron salts during the first two trimesters of gestation in non-anemic women and the development of gestational diabetes mellitus. METHODS: The study used maternal data from the 2015 Pelotas Birth Cohort. All non-anemic women at the 24th week of gestation (n = 2,463) were eligible for this study. Gestational diabetes mellitus was self-reported by women. Crude and adjusted logistic regression were performed considering level of significance = 0.05. RESULTS: Among the women studied, 69.7% were exposed to prophylactic iron supplementation in the first two trimesters of gestation. The prevalence of gestational diabetes mellitus among those exposed was 8.7% (95%CI: 7.4–10.1) and 9.3% (95%CI: 7.4–11.6) among those who were not exposed. Iron supplementation was not associated with increased risk of gestational diabetes mellitus in crude (OR = 0.9; 95%CI: 0,7–1,3) and adjusted analysis (OR = 1.1; 95%CI :0,8–1,6). CONCLUSIONS: The results suggest that routine iron use in non-anemic pregnant women does not increase the risk of developing gestational diabetes. This evidence supports the existing national and international guidelines, in which prophylactic iron supplementation is recommended for all pregnant women as soon as they initiate antenatal care in order to prevent iron deficiency anemia. |
id |
USP-23_2303dbe125ce993a1c90beeceda6578a |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/219139 |
network_acronym_str |
USP-23 |
network_name_str |
Revista de Saúde Pública |
repository_id_str |
|
spelling |
Iron salt supplementation during gestation and gestational diabetes mellitusPharmacoepidemiologyDrug UtilizationCohort StudiesDiabetes, GestationalOBJETIVE: To evaluate the association between the use of iron salts during the first two trimesters of gestation in non-anemic women and the development of gestational diabetes mellitus. METHODS: The study used maternal data from the 2015 Pelotas Birth Cohort. All non-anemic women at the 24th week of gestation (n = 2,463) were eligible for this study. Gestational diabetes mellitus was self-reported by women. Crude and adjusted logistic regression were performed considering level of significance = 0.05. RESULTS: Among the women studied, 69.7% were exposed to prophylactic iron supplementation in the first two trimesters of gestation. The prevalence of gestational diabetes mellitus among those exposed was 8.7% (95%CI: 7.4–10.1) and 9.3% (95%CI: 7.4–11.6) among those who were not exposed. Iron supplementation was not associated with increased risk of gestational diabetes mellitus in crude (OR = 0.9; 95%CI: 0,7–1,3) and adjusted analysis (OR = 1.1; 95%CI :0,8–1,6). CONCLUSIONS: The results suggest that routine iron use in non-anemic pregnant women does not increase the risk of developing gestational diabetes. This evidence supports the existing national and international guidelines, in which prophylactic iron supplementation is recommended for all pregnant women as soon as they initiate antenatal care in order to prevent iron deficiency anemia.Universidade de São Paulo. Faculdade de Saúde Pública2023-09-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/xmlhttps://www.revistas.usp.br/rsp/article/view/21913910.11606/s1518-8787.2023057004871Revista de Saúde Pública; Vol. 57 No. 1 (2023); 71Revista de Saúde Pública; Vol. 57 Núm. 1 (2023); 71Revista de Saúde Pública; v. 57 n. 1 (2023); 711518-87870034-8910reponame:Revista de Saúde Públicainstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/rsp/article/view/219139/200063https://www.revistas.usp.br/rsp/article/view/219139/200062Copyright (c) 2023 Vanessa Iribarrem Avena Miranda, Tatiane da Silva Dal Pizzol, Marysabel Pinto Telis Silveira, Sotero Serrate Mengue, Mariângela Freitas da Silveira, Bárbara Heather Lutz, Andréa Dâmaso Bertoldihttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessMiranda, Vanessa Iribarrem AvenaPizzol, Tatiane da Silva DalSilveira, Marysabel Pinto TelisMengue, Sotero SerrateSilveira, Mariângela Freitas daLutz, Bárbara HeatherBertoldi, Andréa Dâmaso2023-11-22T20:42:47Zoai:revistas.usp.br:article/219139Revistahttps://www.revistas.usp.br/rsp/indexONGhttps://www.revistas.usp.br/rsp/oairevsp@org.usp.br||revsp1@usp.br1518-87870034-8910opendoar:2023-11-22T20:42:47Revista de Saúde Pública - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Iron salt supplementation during gestation and gestational diabetes mellitus |
title |
Iron salt supplementation during gestation and gestational diabetes mellitus |
spellingShingle |
Iron salt supplementation during gestation and gestational diabetes mellitus Miranda, Vanessa Iribarrem Avena Pharmacoepidemiology Drug Utilization Cohort Studies Diabetes, Gestational |
title_short |
Iron salt supplementation during gestation and gestational diabetes mellitus |
title_full |
Iron salt supplementation during gestation and gestational diabetes mellitus |
title_fullStr |
Iron salt supplementation during gestation and gestational diabetes mellitus |
title_full_unstemmed |
Iron salt supplementation during gestation and gestational diabetes mellitus |
title_sort |
Iron salt supplementation during gestation and gestational diabetes mellitus |
author |
Miranda, Vanessa Iribarrem Avena |
author_facet |
Miranda, Vanessa Iribarrem Avena Pizzol, Tatiane da Silva Dal Silveira, Marysabel Pinto Telis Mengue, Sotero Serrate Silveira, Mariângela Freitas da Lutz, Bárbara Heather Bertoldi, Andréa Dâmaso |
author_role |
author |
author2 |
Pizzol, Tatiane da Silva Dal Silveira, Marysabel Pinto Telis Mengue, Sotero Serrate Silveira, Mariângela Freitas da Lutz, Bárbara Heather Bertoldi, Andréa Dâmaso |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Miranda, Vanessa Iribarrem Avena Pizzol, Tatiane da Silva Dal Silveira, Marysabel Pinto Telis Mengue, Sotero Serrate Silveira, Mariângela Freitas da Lutz, Bárbara Heather Bertoldi, Andréa Dâmaso |
dc.subject.por.fl_str_mv |
Pharmacoepidemiology Drug Utilization Cohort Studies Diabetes, Gestational |
topic |
Pharmacoepidemiology Drug Utilization Cohort Studies Diabetes, Gestational |
description |
OBJETIVE: To evaluate the association between the use of iron salts during the first two trimesters of gestation in non-anemic women and the development of gestational diabetes mellitus. METHODS: The study used maternal data from the 2015 Pelotas Birth Cohort. All non-anemic women at the 24th week of gestation (n = 2,463) were eligible for this study. Gestational diabetes mellitus was self-reported by women. Crude and adjusted logistic regression were performed considering level of significance = 0.05. RESULTS: Among the women studied, 69.7% were exposed to prophylactic iron supplementation in the first two trimesters of gestation. The prevalence of gestational diabetes mellitus among those exposed was 8.7% (95%CI: 7.4–10.1) and 9.3% (95%CI: 7.4–11.6) among those who were not exposed. Iron supplementation was not associated with increased risk of gestational diabetes mellitus in crude (OR = 0.9; 95%CI: 0,7–1,3) and adjusted analysis (OR = 1.1; 95%CI :0,8–1,6). CONCLUSIONS: The results suggest that routine iron use in non-anemic pregnant women does not increase the risk of developing gestational diabetes. This evidence supports the existing national and international guidelines, in which prophylactic iron supplementation is recommended for all pregnant women as soon as they initiate antenatal care in order to prevent iron deficiency anemia. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-09-29 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/rsp/article/view/219139 10.11606/s1518-8787.2023057004871 |
url |
https://www.revistas.usp.br/rsp/article/view/219139 |
identifier_str_mv |
10.11606/s1518-8787.2023057004871 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/rsp/article/view/219139/200063 https://www.revistas.usp.br/rsp/article/view/219139/200062 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf text/xml |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Saúde Pública |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Saúde Pública |
dc.source.none.fl_str_mv |
Revista de Saúde Pública; Vol. 57 No. 1 (2023); 71 Revista de Saúde Pública; Vol. 57 Núm. 1 (2023); 71 Revista de Saúde Pública; v. 57 n. 1 (2023); 71 1518-8787 0034-8910 reponame:Revista de Saúde Pública instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Revista de Saúde Pública |
collection |
Revista de Saúde Pública |
repository.name.fl_str_mv |
Revista de Saúde Pública - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
revsp@org.usp.br||revsp1@usp.br |
_version_ |
1800221804026920960 |